Skip to search formSkip to main contentSkip to account menu

Hypercholesterolemia

Known as: Cholesterols, Elevated, Hypercholesterolemia [Disease/Finding], Hypercholesteremia 
A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the… 
National Institutes of Health

Related topics

Related topics

50 relations
ABDOMINAL OBESITY-METABOLIC SYNDROME 3Alagille Syndrome 1Atorvastatin calciumCONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo

Narrower (1)

HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE

Broader (2)

HyperlipidemiaLipid Metabolism Disorders

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease
The National Institute for Health and Clinical Excellence (NICE) guideline, Lipid modification: Cardiovascular risk assessment… 
Highly Cited
1998
Highly Cited
1998
Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography.
BACKGROUND Angiographic studies of the regression of coronary artery disease are invasive and costly, and they permit only… 
Highly Cited
1997
Highly Cited
1997
Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux*
Scavenger receptor BI (SR-BI) binds high density lipoproteins (HDL) with high affinity and mediates the selective uptake of HDL… 
Highly Cited
1996
Highly Cited
1996
Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL.
BACKGROUND Risk factors for atherosclerosis such as hypercholesterolemia and hypertension are associated with endothelial… 
Highly Cited
1994
Highly Cited
1994
Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.
BACKGROUND This study aimed to determine if cholesterol-lowering therapy improves endothelium-dependent coronary vasomotion in… 
Review
1992
Review
1992
Risk factors for coronary artery disease in patients with systemic lupus erythematosus.
Review
1989
Review
1989
The National Cholesterol Education Program.
Review
1988
Review
1988
HMG-CoA reductase inhibitors for treatment of hypercholesterolemia.
THE recent introduction of a unique class of cholesterol-lowering drugs offers new promise for the treatment of… 
Highly Cited
1988
Highly Cited
1988
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.
In the Helsinki Heart Study, a randomized five-year, double-blind trial, a 34% reduction in the incidence of coronary heart… 
Highly Cited
1988
Highly Cited
1988
Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.
Native low density lipoprotein (LDL) does not affect monocyte/macrophage motility. On the other hand, oxidatively modified LDL… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)